Avantor falls after Q4 sales miss

Avantor

07/02/2025 14:12

** Life sciences firm Avantor's shares  AVTR.K  fall 4.37%
to $20.75 premarket
    ** Co posts Q4 sales of $1.69 billion, which missed
analysts' estimates of $1.71 billion, as per data compiled by
LSEG
    ** Sales hurt by foreign currency and the divestiture of its
clinical service business 
    ** Co divested its clinical service business to Audax
private equity firm in a deal valued at ~$650 million last year
    ** Sees 2025 adj profit in the range of $1.02 to $1.10 per
share
    ** Analysts estimate annual profit of $1.10 per share
    ** Up to last close, stock had fallen 11.93% in the last 12
months 

 (Reporting by Siddhi Mahatole)
 ((siddhiprabhanjan.mahatole@thomsonreuters.com))